Becker's Healthcare October 22, 2024
The use of fecal immunochemical testing as a screening tool for colorectal cancer is increasing.
A study published Oct. 22 in Annals of Internal Medicine evaluated the use of FIT in adults aged 45-49, following the recent recommendation to begin regular colorectal cancer screening at age 45. The study, led by Theodore Levin, MD, of Kaiser Permanente in Pleasanton, Calif., analyzed data from over 267,000 patients who received a FIT kit in 2022.
Here are five takeaways from the study:
1. Patients aged 45-49 completed colorectal cancer screening via FIT at about the same rate as those aged 50 when given...
Today's Sponsors
Today's Sponsor